Chandra Bhagat Pharma Ltd

Chandra Bhagat Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Chandra Bhagat Pharma Ltd

₹ 60.0 9.09%
17 Apr - close price
cbcpharma.com BSE - SME: 542934
About

Incorporated in 2003, Chandra Bhagat Pharma Ltd manufactures and trades Pharmaceutical Formulations and API Products[1]

Key Points

Business Overview:[1][2]
Company manufactures formulations and does trading of API in domestic and international markets through its own distribution network and Sales force, under the brand name CBC.
It manufactures formulations by outsourcing to third party on job work basis
a) Major focus on Injection viz. ITV (Intravenous) & IM (Intramuscular), tablets and capsules supply to Hospital and Health care Centre for critical diseases
b) Getting approved formulations manufactured through Contract Manufacturers, Source & Supply of Generic and branded Pharma formulations and medicines to healthcare institution, Government, NGO’s, Hospitals & Distributors
c) Source, deal in Import, indenting and Supply in Specialty Chemicals, Intermediates & Active Pharmaceuticals Ingredients (API)

Website BSE
  • Market Cap ₹ 45.3 Cr.
  • Current Price ₹ 60.0
  • High / Low ₹ 124 / 50.0
  • Stock P/E 28.6
  • Book Value ₹ 39.4
  • Dividend Yield 0.00 %
  • ROCE 7.95 %
  • ROE 5.42 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company's working capital requirements have reduced from 115 days to 60.6 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 3.97% over last 3 years.
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.7.39 Cr.
  • Debtor days have increased from 49.4 to 65.0 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2020 Mar 2021 Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024
22 48 43 51 44 75 119 102 65
21 47 42 50 43 74 124 104 66
Operating Profit 2 2 2 1 1 2 -5 -2 -1
OPM % 7% 3% 4% 2% 2% 2% -4% -2% -2%
0 0 0 1 1 0 7 4 3
Interest 2 2 1 2 1 1 1 1 1
Depreciation 0 0 0 0 0 0 0 0 0
Profit before tax 0 0 1 1 1 1 1 1 1
Tax % 25% 33% 24% 31% 31% 15% 32% 34% -11%
0 0 0 0 0 1 1 1 1
EPS in Rs 0.04 0.21 0.57 0.48 0.49 0.72 0.83 1.19 0.90
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
35 48 61 80 90 97 106 94 71 94 120 221 167
35 46 58 76 85 92 102 91 67 91 116 228 170
Operating Profit 0 2 3 3 4 5 5 3 4 3 3 -7 -3
OPM % 1% 4% 5% 4% 5% 5% 4% 3% 5% 3% 3% -3% -2%
0 1 0 0 0 1 0 0 0 2 0 11 7
Interest 0 2 2 3 4 4 4 3 4 3 2 1 2
Depreciation 0 0 0 0 0 0 0 0 0 0 0 1 1
Profit before tax 0 0 1 1 1 2 1 0 0 1 1 2 2
Tax % 27% 17% 39% 51% 27% 33% 22% 26% 32% 27% 22% 33%
0 0 0 0 1 1 1 0 0 1 1 2 2
EPS in Rs 9.60 8.37 10.29 8.37 15.79 24.64 10.29 0.41 0.25 1.06 1.21 2.03 2.09
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 17%
5 Years: 16%
3 Years: 46%
TTM: -14%
Compounded Profit Growth
10 Years: 16%
5 Years: 17%
3 Years: 100%
TTM: 35%
Stock Price CAGR
10 Years: %
5 Years: 10%
3 Years: -21%
1 Year: -48%
Return on Equity
10 Years: 4%
5 Years: 3%
3 Years: 4%
Last Year: 5%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.25 0.42 0.42 0.42 0.42 0.42 0.67 8 8 8 8 8 8
Reserves 3 6 6 6 7 8 14 18 18 19 20 21 22
11 19 28 28 22 22 31 30 27 21 19 16 23
9 7 8 10 26 28 37 19 19 25 14 56 42
Total Liabilities 24 32 42 44 56 58 83 75 72 72 61 102 95
1 1 1 1 1 1 0 0 0 0 1 3 2
CWIP 0 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 5 1 4 1 0 0 0 0 1
23 31 41 44 51 56 78 74 71 72 60 99 92
Total Assets 24 32 42 44 56 58 83 75 72 72 61 102 95

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0 0 0 0 -9 -6 4 -7 8 12 5 6
0 0 0 0 0 -0 -0 0 0 0 -0 -2
0 0 0 0 8 7 -4 7 -6 -10 -4 -6
Net Cash Flow 0 0 0 0 -1 -0 -0 -0 2 3 1 -1

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 85 65 71 66 80 67 90 54 80 58 25 65
Inventory Days 161 177 123 133 145 174 187 215 153 100 15
Days Payable 53 43 33 81 69 117 53 79 12 11 23
Cash Conversion Cycle 85 174 205 156 132 143 146 188 216 199 114 57
Working Capital Days 107 149 166 134 125 138 139 212 258 165 121 61
ROCE % 2% 12% 10% 10% 15% 17% 13% 7% 7% 9% 7% 8%

Shareholding Pattern

Numbers in percentages

2 Recently
Mar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024
70.42% 70.42% 71.80% 71.80% 70.11% 69.09% 68.24% 68.69% 68.77% 69.29%
0.00% 0.00% 0.00% 0.00% 0.00% 0.85% 0.85% 1.33% 1.33% 0.48%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.89% 0.89% 0.00%
29.58% 29.58% 28.20% 28.20% 29.89% 30.07% 30.91% 29.09% 29.02% 30.23%
No. of Shareholders 17815610690126126146134152315

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings